| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/11/2004 | US20040048883 Novel fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| 03/11/2004 | US20040048880 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 03/11/2004 | US20040048878 Heterocyclic compounds |
| 03/11/2004 | US20040048868 Benzimidazoles |
| 03/11/2004 | US20040048853 Compounds, compositions, and methods |
| 03/11/2004 | US20040048848 Novel gamma secretase inhibitors |
| 03/11/2004 | US20040048847 Increasing the sugar-transporting capacity; preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis |
| 03/11/2004 | US20040048832 Compounds useful in preparing camptothecin derivatives |
| 03/11/2004 | DE20301728U1 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen 5-substituted 7,9-difluoro-5H-chromeno (3,4-f) quinoline compounds as selective progesterone receptor modulator compounds |
| 03/11/2004 | DE10236910A1 Substituierte 1,2,3,4-Tetrahydrochinolinderivate Substituted 1,2,3,4-tetrahydroquinoline |
| 03/10/2004 | EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives |
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 03/10/2004 | EP1395585A1 Antibacterial agents |
| 03/10/2004 | EP1395564A1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1274713B1 Anti-viral pyrimidine nucleoside analogues |
| 03/10/2004 | EP1136477B1 Benzofuran derivatives, process for the preparation of the same and uses thereof |
| 03/10/2004 | CN1481393A N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, their corresponding N-oxides and controlled radical polymerization there with |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/10/2004 | CN1481365A Cyclization process step in making of quinolones and naphthyridines |
| 03/10/2004 | CN1481363A N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as polymerisation in hibitors |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/09/2004 | US6703515 4,5-dicarboxy derivatives of butyrolactones |
| 03/09/2004 | US6703502 Spiroazo bicyclic heterocyclic |
| 03/09/2004 | US6703401 Compounds, their preparation and use |
| 03/09/2004 | US6703399 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| 03/09/2004 | US6703387 Inhibitors of HPV E1 helicase enzyme |
| 03/09/2004 | US6703379 Benzene derivatives and pharmaceutical use thereof |
| 03/04/2004 | WO2004018448A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 03/04/2004 | WO2004018058A2 Compounds, compositions, and methods |
| 03/04/2004 | WO2004017961A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 03/04/2004 | WO2004017922A2 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | WO2004009015A3 Combination therapy for the treatment of obesity |
| 03/04/2004 | WO2003101379A3 Pyranoindazoles and their use for the treatment of glaucoma |
| 03/04/2004 | WO2003098617A3 Optical storage media comprising pentacyclic xanthylium dyes |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003013430A3 Benzoquinone ansamycins |
| 03/04/2004 | WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy |
| 03/04/2004 | US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 03/04/2004 | US20040044198 Reacting chlorin with base; heating, acidification; used for photodynamic therapy |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044030 Cardiovascular disorders; antiarrhythmia agents |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | CA2497632A1 Novel thiophene derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 03/04/2004 | CA2496097A1 Keto cannabinoids with therapeutic indications |
| 03/03/2004 | EP1394159A1 New thiophene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/03/2004 | EP1394156A1 Chromene compound |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1392697A1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f]quinoline |
| 03/03/2004 | EP1392696A1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro 2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide |
| 03/03/2004 | EP1392695A2 Triazolopyrimidines |
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392664A1 Epothilone derivatives |
| 03/03/2004 | EP1392663A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof |
| 03/03/2004 | EP1392658A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
| 03/03/2004 | EP1392656A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392355A1 Use of proteasome inhibitors to treat dry eye disorders |
| 03/03/2004 | EP1392310A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 03/03/2004 | EP1392294A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/03/2004 | EP1392292A2 Pyranoindazoles and their use for the treatment of glaucoma |
| 03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
| 03/03/2004 | EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF |
| 03/03/2004 | EP1277756B1 Ketol fatty acid derivatives and plant growth regulating agents |
| 03/03/2004 | EP0998460B1 Novel tetrazole derivatives |
| 03/03/2004 | EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 03/03/2004 | EP0758333B1 Intermediates in pharmaceutical camptothecin preparation |
| 03/03/2004 | CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/02/2004 | US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders |
| 03/02/2004 | US6700001 Process for stereoselective synthesis of 2-hydroxymethyl chromans |
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 03/02/2004 | US6699875 Cascade esters of camptothecins and methods of treating cancer using these compounds |
| 03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 02/26/2004 | WO2004016576A1 Fused benzene derivative and use |
| 02/26/2004 | WO2003076398A3 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors |
| 02/26/2004 | WO2002098424B1 Novel anti-infectives |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | US20040039040 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 02/26/2004 | US20040039029 Thiazolyl urea compounds and methods of uses |
| 02/26/2004 | US20040039016 HIV protease inhibitors |
| 02/26/2004 | US20040039009 Nitrogen compounds such as 5,6-dihydro-5,11-diketo-11H-indeno (1,2-c)isoquinoline, used as poly/ADP-ribose/ synthase inhibitors in cells, and for prophylaxis of reperfusion injuries, diabetes or inflammation |
| 02/26/2004 | US20040039000 6-aminofuro(2,3-d)pyrimidines and 6-aminopyrrolo(2,3-d) pyrimidines useful in treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii |
| 02/26/2004 | US20040038998 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/26/2004 | US20040038991 Imidazolyl-cyclic acetals |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038971 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 02/26/2004 | US20040038945 Administering pyridoxal-5'-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with a therapeutic cardiovascular compound. |
| 02/26/2004 | US20040038882 Sgk2 and sgk3 used as diagnostic and therapeutic targets |
| 02/26/2004 | US20040038857 Treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage |
| 02/26/2004 | US20040037802 Activated polymeric bicine derivatives such as polypeptides modified with these polymers exhibit reduced immunogenicity/antigenicity and circulate in the blood |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |
| 02/25/2004 | EP1391460A1 Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |